AmiLyfe BioScience LLC

Stephen Gatto is founder, CEO and chairman of AmiLyfe BioScience LLC, a pioneering biotech company at the forefront of a groundbreaking approach to health and wellness using elemental amino acids. AmiLyfe’s breakthroughs have the potential to address a wide range of critical conditions, from combating life-threatening issues like diarrhea, cholera, and malnutrition in children, to preventing heat stroke and alleviating the effects of exertional heat stress, as well as influencing the aging process.

Mr. Gatto has also founded other successful businesses ranging from real estate development and finance, to new technology and innovation platforms.

He is a recognized leader in the development and commercialization of new bio-based products, having founded several technology companies involved in biofuels, bio products and bio-based specialty chemicals. He is actively involved in public policy issues, is a frequent speaker at industry conferences, serves on the advisory board to the Pennsylvania State University, Eberly College of Science, and is a director on the board of Nugentec.